OncoSec Medical Incorporated (ONCS:NASDAQ) soared at $3.85, representing a gain of 51%. The stock got featured on our News Catalysts scanner on Wed, Nov 16, 2022 at 09:58 AM in the 'BIOTECH' category. From Tue, Nov 15, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Tue, Nov 22, 2022 at $6.5 with a volume of 15M+.
About OncoSec Medical Incorporated (ONCS:NASDAQ)
OncoSec Medical Inc is a biotechnology company engaged in designing, developing and commercializing gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer.
Top 10 Gainers:
- Otonomy, Inc. (OTIC:NASDAQ), 113.82%
- Apollo Endosurgery, Inc. (APEN:NASDAQ), 67.83%
- OncoSec Medical Incorporated (ONCS:NASDAQ), 50.98%
- Kalera Public Limited Company (KAL:NASDAQ), 45.16%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 36.47%
- The Very Good Food Company Inc. (VGFC:NASDAQ), 30.71%
- Huadi International Group Co. Ltd. (HUDI:NASDAQ), 27.57%
- Citi Trends, Inc. (CTRN:NASDAQ), 27.46%
- Renalytix AI plc (RNLX:NASDAQ), 24.5%
- Bilibili Inc. (BILI:NASDAQ), 22.32%